Aspects of mental health dysfunction among survivors of childhood cancer by Fidler, Miranda M et al.
 
 
University of Birmingham
Aspects of mental health dysfunction among
survivors of childhood cancer
Fidler, Miranda M; Ziff, Oliver J; Wang, Sarra; Cave, Joshua; Janardhanan, Pradeep; Winter,
David L; Kelly, Julie; Mehta, Susan; Jenkinson, Helen; Frobisher, Clare; Reulen, Raoul C;
Hawkins, Michael M
DOI:
10.1038/bjc.2015.310
License:
Creative Commons: Attribution (CC BY)
Document Version
Publisher's PDF, also known as Version of record
Citation for published version (Harvard):
Fidler, MM, Ziff, OJ, Wang, S, Cave, J, Janardhanan, P, Winter, DL, Kelly, J, Mehta, S, Jenkinson, H, Frobisher,
C, Reulen, RC & Hawkins, MM 2015, 'Aspects of mental health dysfunction among survivors of childhood
cancer', British Journal of Cancer, vol. 113, no. 7, pp. 1121-1132. https://doi.org/10.1038/bjc.2015.310
Link to publication on Research at Birmingham portal
Publisher Rights Statement:
Eligibility for repository : checked 16/10/2015
General rights
Unless a licence is specified above, all rights (including copyright and moral rights) in this document are retained by the authors and/or the
copyright holders. The express permission of the copyright holder must be obtained for any use of this material other than for purposes
permitted by law.
•	Users may freely distribute the URL that is used to identify this publication.
•	Users may download and/or print one copy of the publication from the University of Birmingham research portal for the purpose of private
study or non-commercial research.
•	User may use extracts from the document in line with the concept of ‘fair dealing’ under the Copyright, Designs and Patents Act 1988 (?)
•	Users may not further distribute the material nor use it for the purposes of commercial gain.
Where a licence is displayed above, please note the terms and conditions of the licence govern your use of this document.
When citing, please reference the published version.
Take down policy
While the University of Birmingham exercises care and attention in making items available there are rare occasions when an item has been
uploaded in error or has been deemed to be commercially or otherwise sensitive.
If you believe that this is the case for this document, please contact UBIRA@lists.bham.ac.uk providing details and we will remove access to
the work immediately and investigate.
Download date: 01. Mar. 2020
Aspects of mental health dysfunction among
survivors of childhood cancer
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Julie Kelly1, Susan Mehta2, Helen Jenkinson3, Clare Frobisher1, Raoul C Reulen1 and Michael M Hawkins*,1
on behalf of the British Childhood Cancer Survivor Study (BCCSS) Steering Group
1Department of Public Health, Epidemiology and Biostatistics, Centre for Childhood Cancer Survivor Studies, School of Health
and Population Sciences, Public Health Building, University of Birmingham, Birmingham B15 2TT, UK; 2Department of Oncology,
University College London Hospital, 1st Floor Central, 250 Euston Road, London NW1 2PG, UK and 3Department of Oncology,
Birmingham Children’s Hospital, NHS Foundation Trust, Steelhouse Lane, Birmingham B4 6NH, UK
Background: Some previous studies have reported that survivors of childhood cancer are at an increased risk of developing long-
term mental health morbidity, whilst others have reported that this is not the case. Therefore, we analysed 5-year survivors of
childhood cancer using the British Childhood Cancer Survivor Study (BCCSS) to determine the risks of aspects of long-term
mental health dysfunction.
Procedure: Within the BCCSS, 10 488 survivors completed a questionnaire that ascertained mental health-related information via
10 questions from the Short Form-36 survey. Internal analyses were conducted using multivariable logistic regression to determine
risk factors for mental health dysfunction. External analyses were undertaken using direct standardisation to compare mental
health dysfunction in survivors with UK norms.
Results: This study has shown that overall, childhood cancer survivors had a significantly higher prevalence of mental health
dysfunction for 6/10 questions analysed compared to UK norms. Central nervous system (CNS) and bone sarcoma survivors
reported the greatest dysfunction, compared to expected, with significant excess dysfunction in 10 and 6 questions, respectively;
the excess ranged from 4.4–22.3% in CNS survivors and 6.9–15.9% in bone sarcoma survivors. Compared to expected, excess
mental health dysfunction increased with attained age; this increase was greatest for reporting ‘limitations in social activities due
to health’, where the excess rose from 4.5% to 12.8% in those aged 16–24 and 45þ , respectively. Within the internal analyses,
higher levels of educational attainment and socio-economic classification were protective against mental health dysfunction.
Conclusions: Based upon the findings of this large population-based study, childhood cancer survivors report significantly higher
levels of mental health dysfunction than those in the general population, where deficits were observed particularly among CNS
and bone sarcoma survivors. Limitations were also observed to increase with age, and thus it is important to emphasise the need
for mental health evaluation and services across the entire lifespan. There is evidence that low educational attainment and being
unemployed or having never worked adversely impacts long-term mental health. These findings provide an evidence base for risk
stratification and planning interventions.
Although 5-year survival from childhood cancer has risen sub-
stantially to B80% (Stiller, 2007), long-term survival is accom-
panied by an excess risk of adverse outcomes due to late effects of
the cancer and its treatment. Consequently, as the number of
survivors increases, it becomes ever more important to investigate
the risk of such adverse effects to identify vulnerable subgroups.
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While previous studies have investigated health status among
childhood cancer survivors, mental health sequelae remains a
concern as psychological limitations or distress have been reported
in both adolescent and adult survivors of childhood cancer (Schultz
et al, 2007; Gurney et al, 2009; Zeltzer et al, 2009; Gianinazzi et al,
2013). Additionally, conflicting findings on mental health have been
reported (Reulen et al, 2007; Zeltzer et al, 2009). By identifying
survivors at risk for mental health dysfunction, appropriate
monitoring and early interventions within long-term care can be
undertaken through risk stratification to ensure that young people
and adults achieve the best possible outcomes in terms of health and
social welfare, whilst optimising the expenditure of limited resources.
The goal of this study was to investigate specific aspects of
mental health dysfunction among childhood cancer survivors
diagnosed between the age of 0–14 years within the British
Childhood Cancer Survivor Study (BCCSS) by assessing responses
to specific questions within the Short Form-36 (SF-36) survey.
Although studies have assessed aspects of mental health using this
survey previously (Recklitis et al, 2003; Pemberger et al, 2005;
Maunsell et al, 2006; Reulen et al, 2007; Zeltzer et al, 2008; Zeltzer
et al, 2009), this is the first study to our knowledge to
comprehensively analyse the 10 questions comprising the role
emotional, social functioning, and mental health scales, which have
been shown to be the most valid among the scales as mental health
measures (Ware et al, 1993; Ware, 2000). By looking at specific
questions, one can better determine the effect of various aspects of
mental health dysfunction, which may have been previously
undetected in a composite score or individual scale. The potential
impact of demographic, cancer, social, and economic explanatory
factors on mental health were explored and external analyses
comparing survivors to general population norms were conducted.
In doing so, this large, population-based study provides further
evidence on mental health morbidity among childhood cancer
survivors, which may have important implications for clinicians,
family members, and survivors with regard to minimising mental
health adverse late effects.
MATERIALS AND METHODS
Study population. The BCCSS is a population-based cohort of
17 980 individuals diagnosed with cancer before the age of 15,
between 1940–1991 in Great Britain, and who have survived at
least 5 years (Hawkins et al, 2008). The cohort was ascertained
through the National Registry of Childhood Tumours, which has a
high estimated level of completeness (B99%) (Kroll et al, 2011).
Ethical approval for the study was obtained from a Multi-Centre
Research Ethics Committee and every Local Research Ethics
Committee in Britain (N¼ 212 in total).
Short Form-36 survey. It was important to measure both health
and social impacts on quality of life to understand the effect of
childhood cancer treatment on long-term mental health. To
ascertain health and social outcomes, a questionnaire was sent to
all survivors in the BCCSS cohort who were alive and aged at least
16 years at questionnaire send-out (questionnaire return date range:
2001–2007, questionnaire return date median: 2002). Of the 14 836
survivors who were eligible to receive the questionnaire, 10 488
(70.7%) completed the survey (Hawkins et al, 2008). Included in the
questionnaire was the SF-36, which is a generic health survey that
contains 36 questions, which measure 8 dimensions of health status.
From our previous work, which studied the psychometric properties
of the SF-36 in the BCCSS population, we know that this survey
exhibits good validity and reliability when used in long-term
survivors of childhood cancer (Reulen et al, 2006).
Using the available information from the SF-36, we assessed
specific aspects of mental health dysfunction, henceforth only
referred to as mental health dysfunction, by looking at the 10
individual questions that comprise the role emotional, social
functioning, and mental health scales (Ware et al, 1993; Ware,
2000). To assess mental health dysfunction from the responses to
each question, we dichotomised the responses (Figure 1). For the
mental health scale (questions 9b, 9c, 9d, 9f, and 9h) and one
question relating to social functioning (question 9j), we dichot-
omised the responses based on whether the sentence was positively
or negatively worded, where survivors were considered to be
reporting dysfunction if they answered ‘all’, ‘most’, ‘a good bit’, or
‘some’ of the time to the negatively worded questions and ‘some’, ‘a
little’, or ‘none of the time’ to the positively worded questions. The
second social functioning question (question 6), which assessed
physical or emotional interference in normal social activities, was
dichotomised by categorising responses of ‘not at all’ or ‘slightly’ as
not reporting dysfunction and responses of ‘moderately’, ‘quite a
bit’, or ‘extremely’ as reporting dysfunction. For the role-emotional
scale (questions 5a, 5b, and 5c), survivors who reported ‘yes’ were
considered to be reporting mental health dysfunction. These
dichotomised groupings were used to avoid the problems
associated with having almost all survivors occupying one level
of the dichotomy for responses to any question.
Comparison group. To compare responses to the 10 questions
between survivors and the general population, the SF-36 responses
from the Oxford Healthy Life Survey (OHLS) served as the
reference general population sample (Jenkinson et al, 1993;
Jenkinson, 1996). The OHLS was conducted between 1991 and
1992 and included 13 042 individuals aged 18–64 who were
randomly sampled from the Family Health Services Authority
registers for Berkshire, Buckinghamshire, Northamptonshire and
Oxfordshire. The OHLS sample resembles the UK general
population with regard to socio-demographic characteristics
(Jenkinson, 1996) and thus serves as an appropriate general
population sample. Furthermore, the OHLS used identical
questions and the same standardised method for self completion
as the BCCSS questionnaire; when the characteristics of the OHLS
were previously compared with BCCSS survivors only slight
differences were observed in regards to sex and age (Reulen et al,
2007). The OHLS responses to the SF-36 were dichotomised as
described above so that responses from survivors and the general
population sample were treated identically.
Statistical analyses–internal comparison. Internal analyses, using
multivariable logistic regression, were conducted to determine risk
factors for mental health dysfunction among 5-year childhood
cancer survivors within each of the 10 questions. All models
adjusted for the following factors: age at diagnosis, sex, first
primary neoplasm (FPN) diagnosis, age at questionnaire comple-
tion, marital status, socio-economic classification, and educational
attainment. We decided a priori to use leukaemia survivors as the
referent group because previously published literature on health
status has been conducted in this manner (Hudson et al, 2003).
Odds ratios (ORs) and 95% confidence intervals (CIs) were
reported. Likelihood ratio tests were used to assess the significance
of fitted models and trends.
Statistical analyses–external comparison. To compare the pre-
valence of mental health dysfunction between survivors and the
general population, external analyses were completed using direct
(age and sex) standardisation, which would address any small
differences in the characteristics between the BCCSS and OHLS.
For these analyses, the general population sample acted as the
reference group and survivors were compared overall and
separately by FPN diagnosis and attained age. Prevalence of
mental health dysfunction was reported as percentages with
corresponding 95% CIs.
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All analyses were undertaken using Stata 13.1 (StataCorp,
College Station, TX, USA). Statistical significance was defined as a
two-sided P-value o0.05.
RESULTS
Survivors who were female, treated for a FPN of a central
nervous system (CNS) tumour, unemployed or having never
worked, or educationally unqualified were found to consistently
report the highest prevalence of dysfunction across all 10
questions (Supplementary Table 1). Survivors who were
separated, divorced, or widowed also generally reported more
dysfunction than those who were single, cohabiting, or married.
Mental health dysfunction within the 10 questions did not
appear to differ substantially by age at diagnosis, treatment
modalities (radiotherapy, chemotherapy, and surgery), or age at
questionnaire completion.
Figure 1. SF-36v1 questions assessed for mental health dysfunction. Checked boxes denote responses that were considered as ‘reporting mental
health dysfunction’.
Mental health among survivors of childhood cancer BRITISH JOURNAL OF CANCER
www.bjcancer.com |DOI:10.1038/bjc.2015.310 1123
Internal comparison
Risk factors associated with reporting mental health dysfunction
within the role-emotional scale. Table 1 presents the multi-
variable models for the three mental health questions within the
role-emotional scale. Females were significantly more likely to be
limited in all three questions (all Po0.0001). Across FPN
diagnoses there were statistically significant heterogeneity for all
three questions where, compared with leukaemia survivors,
survivors of non-Hodgkin lymphoma (NHL), CNS tumours, and
bone sarcoma were significantly more likely to be limited for all
questions (all Po0.05). Also, compared with leukaemia survivors,
heritable retinoblastoma survivors reported significantly more
mental health dysfunction in having to ‘cut down on the amount of
time you spent on work or other activities’ (OR: 1.7(1.1–2.4))
and in having ‘accomplished less than you would like’ (OR:
1.7(1.2–2.3)), whereas Hodgkin lymphoma (HL) survivors
reported significantly more dysfunction in having ‘did work or
other activities less carefully than usual’ (OR: 1.4(1.0–1.8)).
Compared with individuals aged 16–24 at questionnaire comple-
tion, the risk for reporting mental health dysfunction in all
three questions increased linearly with age (all Ptrendo0.01). An
analysis by marital status showed for all three questions that,
relative to single survivors, those who were separated were most
at risk of reporting dysfunction, whereas those who were
married were significantly less likely to report dysfunction.
An association was found for educational attainment, where
increased qualifications were associated with decreased odds of
reporting dysfunction in all three questions. For all three
questions, relative to students, survivors who had never worked
or were unemployed were significantly more likely to report
mental health dysfunction, whereas those who were in manage-
rial or professional positions were significantly less likely to
report dysfunction.
Risk factors associated with reporting mental health dysfunction
within the social functioning scale. In the multivariable models
assessing the two questions within the social functioning scale,
females were again significantly more likely to report dysfunction
compared to males (Table 2). An analysis by FPN diagnosis
showed that compared with those diagnosed with leukaemia, CNS
(OR: 1.6(1.4–1.9)), neuroblastoma (OR: 1.5(1.1–2.0)), bone
sarcoma (OR: 2.0(1.5–2.7)), and soft tissue sarcoma (OR:
1.3(1.0–1.7)) survivors were all significantly more likely to report
mental health dysfunction in ‘has your physical health or
emotional problems interfered with your normal social activities.’
NHL, CNS, neuroblastoma, heritable retinoblastoma, bone sar-
coma, and soft tissue sarcoma survivors also reported significantly
higher dysfunction in ‘has your health limited your social
activities’, compared with leukaemia survivors, with bone sarcoma
(OR: 3.0(2.3–4.0)) and CNS survivors (OR: 2.5(2.1–2.9)) being the
most limited. Age at questionnaire completion was significantly
associated with reporting dysfunction in both questions where
those aged 25–34, 35–44, and 45þ reported more dysfunction
compared with those aged 16–24 (both Ptrendo0.0001). Relative
to single survivors, married survivors were significantly less likely
to report dysfunction in either question (both Po0.001); no
significant difference was found between single survivors and those
who were cohabiting, separated, divorced, or widowed. An analysis
by educational attainment showed that, compared with survivors
with no qualifications, the odds of reporting mental health
dysfunction decreased with higher levels of qualifications for both
questions. Socio-economic classification was also found to be
significantly related to reporting dysfunction in both questions
where, compared with students, those who never worked or were
unemployed were significantly more likely to report dysfunction
(both Po0.001) and those in managerial or professional positions
were significantly less likely to report dysfunction (both Pp0.001).
Risk factors associated with reporting mental health dysfunction
within the mental health scale. Survivors who were female or
who had never worked or were unemployed were significantly
more likely to report mental health dysfunction in all five
questions within in the mental health scale relative to males and
students, respectively, (Table 3). Conversely, survivors who
achieved an O-level, A-level, teaching qualification, or degree
were significantly less likely to report dysfunction in all questions
compared with students. Age at questionnaire completion was
also found to be significantly associated with reporting dysfunc-
tion in 4/5 questions, but a consistent trend was not observed
within the subgroups compared with those aged 16–24. When
analysed by marital status, survivors who were married were
found to report significantly less mental health dysfunction in 4/
5 of the questions, compared with those who were single.
Survivors who were cohabiting also reported significantly less
mental health dysfunction for the question relating to having
‘been a very nervous person’ (OR: 0.8(0.7–1.0)). Survivors who
were separated, conversely, reported a 70% increase in
mental health dysfunction compared with single survivors (OR:
1.7(1.2–2.4)). When asked if the survivor had ‘been a very
nervous person’, those diagnosed with CNS (OR: 1.3(1.1–1.5)),
compared with leukaemia, were significantly more likely
to agree with this statement. Furthermore, in the multi-
variable model assessing whether survivors had ‘been a happy
person’, an analysis by FPN diagnosis showed that HL (OR:
1.3(1.0–1.6)), NHL (OR: 1.4(1.1–1.8)), CNS (OR: 1.4(1.2–1.6)),
neuroblastoma (OR: 1.3(1.0–1.7)), non-heritable retinoblastoma
(OR: 1.4(1.0–1.8)), and bone sarcoma (OR: 1.5(1.1–1.9)) survivors
reported significantly higher dysfunction compared with leukaemia
survivors.
External comparison. Compared with the general population
sample, survivors overall reported more mental health dysfunction
in 6/10 questions that were examined (Table 4). When further
assessed by FPN diagnosis, CNS and bone sarcoma survivors were
found to report the greatest dysfunction, compared with that
expected, with significant differences in 10 and 6 questions,
respectively; the excess of dysfunction ranged from 4.4–22.3% in
CNS survivors, whereas bone sarcoma survivors were limited from
6.9–15.9%. Both diagnostic groups were most disadvantaged by
their health limiting their social activities. Conversely, survivors of
neuroblastoma, heritable retinoblastoma, non-heritable retinoblas-
toma, Wilms, and other (those that did not conform to one of the
10 FPN groups used) were not significantly different in any of the
questions analysed when compared with the general population
sample.
An analysis by age at questionnaire completion showed that
the prevalence of mental health dysfunction was comparable or
better for 7/10 questions among survivors aged 16–24, compared
with that expected from the general population sample (Table 5);
survivors in this age group did however report a higher
prevalence of having ‘been a nervous person’ (30.7% vs 23.7%
expected), ‘felt so down in the dumps that nothing could cheer
you up’ (25.3% vs 21.2% expected), and in ‘has your health
limited your social activities’ (15.7% vs 11.2% expected). Among
those aged 25–34 and 35–44 at questionnaire completion,
significantly higher mental health dysfunction was reported,
compared with the general population sample, in relation to six
questions (questions 5a, 6, 9b, 9c, 9f, and 9j). Similarly, survivors
aged 45 and older reported significantly higher dysfunction in
five questions compared with that expected. Notably, the per
cent difference in mental health dysfunction between survivors
and the general population increased with age at questionnaire
completion for both questions from the social functioning scale
and the question ‘have you felt downhearted and blue’; this
increase was most noticeable in the question ‘has your health
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limited your social activities,’ where the excess rose from 4.5% to
12.8% in those aged 16–24 and 45þ , respectively. Statistically
significant variation in the excess by age at questionnaire
completion was not observed in four questions, which related
to problems with work or daily activities and feeling calm,
peaceful, or happy.
Table 1.Multivariable logistic regression modelsa reporting ORs and 95% CIs for reporting mental health dysfunction within the
three questionsb comprising the role-emotional scale of the SF-36 survey, by specific potential demographic, cancer, social, and
economic factors
Cut down on the amount of time you
spent on work or other activities?
(question 5a)
Accomplished less than you would like?
(question 5b)
Did work or other activities less
carefully than ususal? (question 5c)
Characteristic
OR
(95% CI) P-value
Pheterogeneityc
(Ptrendd)
OR
(95% CI) P-value
Pheterogeneityc
(Ptrendd)
OR
(95% CI) P-value
Pheterogeneityc
(Ptrendd)
Sex
Male 1.0 1.0 1.0
Female 1.6 (1.4–1.8) o0.001 o0.0001 1.5 (1.3–1.7) o0.001 o0.0001 1.8 (1.6–2.0) o0.001 o0.0001
Diagnosis
Leukaemia 1.0 1.0 1.0
Hodgkin lymphoma 1.2 (0.9–1.5) 0.317 1.0 (0.8–1.3) 0.723 1.4 (1.0–1.8) 0.024
Non-Hodgkin lymphoma 1.4 (1.1–1.9) 0.019 1.4 (1.1–1.7) 0.019 1.6 (1.2–2.1) 0.001
Central nervous system 1.6 (1.4–2.0) o0.001 1.5 (1.2–1.7) o0.001 1.5 (1.2–1.8) o0.001
Neuroblastoma 1.4 (1.0–1.9) 0.055 1.3 (1.0–1.7) 0.077 1.1 (0.8–1.6) 0.437
Non-heritable
Retinoblastoma
1.1 (0.8–1.6) 0.496 1.1 (0.8–1.5) 0.687 1.0 (0.7–1.4) 0.967
Heritable retinoblastoma 1.7 (1.1–2.4) 0.011 1.7 (1.2–2.3) 0.002 1.3 (0.9–1.9) 0.205
Wilms 1.2 (1.0–1.6) 0.105 1.0 (0.8–1.3) 0.838 1.1 (0.9–1.5) 0.256
Bone sarcoma 1.7 (1.2–2.4) 0.001 1.4 (1.1–1.9) 0.014 1.5 (1.1–2.1) 0.008
Soft tissue sarcoma 1.5 (1.1–1.9) 0.006 1.2 (1.0–1.5) 0.082 1.5 (1.1–1.9) 0.003
Other 0.9 (0.7–1.2) 0.673 o0.0001 1.0 (0.8–1.3) 0.693 o0.0001 1.0 (0.8–1.3) 0.927 0.0005
Age at diagnosis
0–4 years 1.0 1.0 1.0
5–9 years 1.2 (1.0–1.4) 0.029 1.3 (1.1–1.5) 0.001 1.1 (0.9–1.2) 0.530
10–14 years 1.2 (1.0–1.5) 0.026 0.0462
(0.0282)
1.3 (1.1–1.5) 0.003 0.0019
(0.0029)
1.1 (1.0–1.4) 0.147 0.3433
(0.1380)
Age at questionnaire completion
16–24 years 1.0 1.0 1.0
25–34 years 1.4 (1.1–1.7) 0.001 1.3 (1.1–1.5) 0.001 1.3 (1.1–1.5) 0.009
35–44 years 1.6 (1.2–2.0) o0.001 1.6 (1.3–2.0) o0.001 1.4 (1.2–1.8) 0.001
45þ years 1.4 (1.1–1.9) 0.012 0.0016
(0.0004)
1.6 (1.2–2.0) o0.001 o0.0001
(o0.0001)
1.2 (0.9–1.6) 0.124 0.0087
(0.0054)
Marital status
Single 1.0 1.0 1.0
Cohabiting 1.1 (0.9–1.4) 0.226 1.1 (0.9–1.4) 0.166 1.0 (0.8–1.2) 0.971
Married 0.7 (0.6–0.9) 0.002 0.7 (0.6–0.8) o0.001 0.7 (0.5–0.8) o0.001
Separated 1.5 (1.0–2.4) 0.047 1.6 (1.1–2.4) 0.013 1.6 (1.0–2.3) 0.031
Divorced 1.2 (0.9–1.6) 0.333 1.1 (0.8–1.4) 0.495 1.1 (0.8–1.4) 0.613
Widowed 0.7 (0.2–2.2) 0.603 0.0001 0.8 (0.3–2.0) 0.583 o0.0001 1.1 (0.4–2.9) 0.817 o0.0001
Educational attainment
No qualifications 1.0 1.0 1.0
Other qualifications 0.7 (0.6–0.9) 0.010 0.8 (0.6–0.9) 0.010 0.8 (0.6–1.0) 0.040
O-levele 0.7 (0.5–0.8) o0.001 0.7 (0.6–0.8) o0.001 0.8 (0.6–0.9) 0.005
A-levelf 0.7 (0.6–0.9) 0.001 0.7 (0.6–0.9) 0.002 0.7 (0.6–0.9) 0.003
Teaching qualification 0.6 (0.5–0.8) 0.002 0.7 (0.5–0.8) 0.001 0.8 (0.6–1.0) 0.037
Degree 0.6 (0.5–0.8) o0.001 0.0004 0.7 (0.6–0.9) 0.003 0.0044 0.7 (0.5–0.9) 0.002 0.0030
SEC
Student 1.0 1.0 1.0
Never worked/
unemployed
1.5 (1.2–2.0) 0.003 1.4 (1.1–1.8) 0.003 1.3 (1.0–1.8) 0.030
Routine/manual 0.9 (0.7–1.1) 0.424 0.8 (0.7–1.0) 0.030 1.0 (0.8–1.2) 0.893
Intermediate 0.9 (0.7–1.1) 0.290 0.8 (0.7–1.0) 0.060 0.8 (0.7–1.1) 0.155
Managerial/professional 0.7 (0.5–0.9) 0.005 o0.0001 0.7 (0.5–0.8) o0.001 o0.0001 0.8 (0.6–1.0) 0.025 0.0004
Abbreviations: CI¼ confidence intervals; OR¼odds ratio; SEC¼ socio-economic classification.
aAdjusted for age at diagnosis, diagnosis, sex, age at questionnaire completion, marital status, educational attainment, and SEC.
bTo view full questions, please refer to Figure 1.
cThe Pheterogeneity (two-sided) is from the likelihood ratio test for heterogeneity in the probability of reporting mental health dysfunction within this specific question, across different levels of
the specified explanatory factor with adjustment for all other factors in the multivariable model. The threshold for statistical significant was 0.05.
dThe Ptrend (two-sided) is from the test for trend, where the threshold for statistical significant was 0.05.
eDegree received at age 16.
fDegree received at age 18.
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DISCUSSION
The findings from this large population-based study indicate that
the prevalence of mental health dysfunction among survivors of
childhood cancer in the BCCSS was substantially higher than that
expected from the general population sample in over half of the
questions assessed, with survivors of CNS and bone sarcoma being
the most vulnerable; these findings are generally consistent with
other studies that have used the SF-36 (Maunsell et al, 2006) or
Table 2.Multivariable logistic regression modelsa reporting ORs and 95% CIs for reporting mental health dysfunction within the
two questions comprising the social functioningb scale of the SF-36 survey, by specific potential demographic, cancer, social, and
economic factors
Has your physical health or emotional
problems interfered with your normal
social activities? (question 6)
Has your health limited your
social activities? (question 9j)
Characteristic
OR
(95% CI) P-value
Pheterogeneityc
(Ptrendd)
OR
(95% CI) P-value
Pheterogeneityc
(Ptrendd)
Sex
Male 1.0 1.0
Female 1.5 (1.3–1.7) o0.001 o0.0001 1.5 (1.4–1.7) o0.001 o0.0001
Diagnosis
Leukaemia 1.0 1.0
Hodgkin lymphoma 0.9 (0.7–1.2) 0.703 1.2 (0.9–1.5) 0.284
Non-Hodgkin lymphoma 1.3 (1.0–1.7) 0.079 1.5 (1.1–2.0) 0.004
Central nervous system 1.6 (1.4–1.9) o0.001 2.5 (2.1–2.9) o0.001
Neuroblastoma 1.5 (1.1–2.0) 0.011 1.5 (1.1–2.0) 0.020
Non-heritable retinoblastoma 1.0 (0.7–1.4) 0.812 1.0 (0.7–1.5) 0.864
Heritable retinoblastoma 1.3 (0.9–1.9) 0.197 1.5 (1.0–2.2) 0.037
Wilms 1.1 (0.8–1.3) 0.896 1.1 (0.9–1.5) 0.275
Bone sarcoma 2.0 (1.5–2.7) o0.001 3.0 (2.3–4.0) o0.001
Soft tissue sarcoma 1.3 (1.0–1.7) 0.036 1.6 (1.2–2.0) o0.001
Other 1.0 (0.7–1.2) 0.692 o0.0001 1.2 (0.9–1.5) 0.224 o0.0001
Age at diagnosis
0–4 years 1.0 1.0
5–9 years 1.1 (0.9–1.3) 0.377 1.1 (0.9–1.2) 0.462
10–14 years 1.1 (1.0–1.4) 0.137 0.3297
(0.1368)
1.1 (0.9–1.3) 0.258 0.5227
(0.2821)
Age at questionnaire completion
16–24 years 1.0 1.0
25–34 years 1.5 (1.3–1.8) o0.001 1.8 (1.5–2.2) o0.001
35–44 years 1.6 (1.3–1.8) o0.001 2.0 (1.6–2.5) o0.001
45þ years 1.5 (1.2–2.0) 0.002 o0.0001
(o0.0001)
2.1 (1.6–2.7) o0.001 o0.0001
(o0.0001)
Marital status
Single 1.0 1.0
Cohabiting 1.1 (0.9–1.3) 0.419 1.0 (0.8–1.2) 0.940
Married 0.7 (0.6–0.9) o0.001 0.7 (0.6–0.8) o0.001
Separated 1.3 (0.9–2.0) 0.176 1.2 (0.8–1.8) 0.447
Divorced 1.1 (0.9–1.5) 0.339 1.0 (0.8–1.3) 0.969
Widowed 1.2 (0.5–2.9) 0.709 0.0001 1.6 (0.7–3.8) 0.255 0.0001
Educational attainment
No qualifications 1.0 1.0
Other qualifications 0.7 (0.6–0.9) o0.001 0.7 (0.6–0.8) o0.001
O-levele 0.6 (0.5–0.7) o0.001 0.5 (0.4–0.6) o0.001
A-levelf 0.6 (0.5–0.7) o0.001 0.4 (0.4–0.5) o0.001
Teaching qualification 0.5 (0.4–0.7) o0.001 0.5 (0.4–0.6) o0.001
Degree 0.5 (0.4–0.6) o0.001 o0.0001 0.4 (0.3–0.5) o0.001 o0.0001
SEC
Student 1.0 1.0
Never worked/unemployed 1.6 (1.3–2.1) o0.001 1.7 (1.3–2.2) o0.001
Routine/manual 0.9 (0.7–1.1) 0.384 0.9 (0.7–1.1) 0.402
Intermediate 0.9 (0.7–1.1) 0.329 0.9 (0.7–1.1) 0.224
Managerial/professional 0.7 (0.5–0.9) 0.001 o0.0001 0.7 (0.5–0.9) o0.001 o0.0001
Abbreviations: CI¼ confidence intervals; OR¼odds ratio; SEC¼ socio-economic classification.
aAdjusted for age at diagnosis, diagnosis, sex, age at questionnaire completion, marital status, educational attainment, and SEC.
bTo view full questions, please refer to Figure 1.
cThe Pheterogeneity (two-sided) is from the likelihood ratio test for heterogeneity in the probability of reporting mental health dysfunction within this specific question, across different levels of
the specified explanatory factor with adjustment for all other factors in the multivariable model. The threshold for statistical significant was 0.05.
dThe Ptrend (two-sided) is from the test for trend, where the threshold for statistical significant was 0.05.
eDegree received at age 16.
fDegree received at age 18.
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similar psychological measures (Hudson et al, 2003; Zebrack et al,
2004; Zeltzer et al, 2009), although some studies have suggested
that mental health status was similar between survivors and
comparative populations (Reulen et al, 2007; Zeltzer et al, 2009;
Phipps et al, 2014). While the North American Childhood Cancer
Survivor Study (CCSS) found significantly higher limitations in the
role emotional and social functioning scales for survivors overall,
survivors of CNS and bone sarcoma were reported as having
significantly less problems on the mental health scale compared to
that expected from the US population reference (Zeltzer et al,
2008); this finding does not correspond with our results as CNS
and bone sarcoma survivors were found to be significantly more
limited in 5/5 and 3/5 of the questions that comprise the mental
health scale, respectively. The same study (Zeltzer et al, 2008) also
reported significantly higher limitations in regards to the role
emotional and social functioning scales for HL, NHL, Wilms, and
neuroblastoma survivors, compared with US norms, which
conflicts with the results presented in this study as these survivors
were not significantly more limited in any of the questions
comprising these scales compared with the general population
sample. Although the CCSS and this study used different
methodologies, with the CCSS using means and this study using
proportions when assessing differences between childhood cancer
survivors and general population norms, broad patterns of
agreement in the findings from the CCSS and this study are
expected as both studies adjusted for sex and age. These
inconsistencies with our study might reflect differences in study
demographics, cohort design, or therapeutic practice between
North America and Great Britain.
Another important finding in this study was that, although
younger survivors (16–24 years) perceived their mental health as
broadly similar to the general population, significant mental health
dysfunction was reported in at least half of the questions among
those aged 25 years and older. A particular concern was found
among the questions relating to social functioning as significant
mental health dysfunction was reported for all age groups.
Furthermore, the extent of the excess among survivors increased
with age at questionnaire completion for both questions within the
social functioning scale. This finding corresponds with another
study that reported significantly more disadvantage in the social
functioning scale in those assessed 10–14 and 15–19 years from
diagnosis compared to a control group (Maunsell et al, 2006).
A possible explanation as to why mental health dysfunction
increased with age may be due to the fact that the risk of complex
and multiple late effects emerging increases as time since treatment
increases (Oeffinger et al, 2006; Geenen et al, 2007; Hudson et al,
2013; Armstrong et al, 2014). Although late effects may not
immediately affect survivors, they may become more important
with maturity and influence life decisions and experiences later on.
For example, infertility may become a greater concern and impact
mental health when survivors want to start a family. Living with
chronic health conditions, such as infertility, cardiovascular
disease, diabetes, blindness, physical disability, and epilepsy, which
can often be managed but not cured, may have long-term
consequences on both physical and psychological health, stressing
the importance for life course care and services.
The internal analyses similarly revealed that CNS and bone
sarcoma survivors reported higher levels of mental health
dysfunction compared to other types of childhood cancer, with
CNS survivors being limited in all questions assessed and bone
sarcoma survivors being limited in all questions relating to the
social functioning and role-emotional scales. Broadly, this finding
conflicts with an analysis by the CCSS, which found no significant
difference among childhood cancer survivors by FPN diagnosis
(Hudson et al, 2003); however, it is worth noting that in the CCSS
the Brief Symptom Inventory 18 survey was used and thus results
are not directly comparable. Other risk factors for mental healthT
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dysfunction included being female, separated from a spouse/
partner, and unemployed or having never worked, which
corresponds with previous reports using the SF-36 (Zeltzer et al,
2008; Zeltzer et al, 2009) or similar measures to predict
psychological distress (Hudson et al, 2003). Low educational
attainment, unemployment, and other socio-economic disadvan-
tages are recognised risks to mental health in the general
population (Marmot, 2010). However, the effects of these
determinants may be even more detrimental among childhood
cancer survivors as these individuals, when assessed with
comparative norms, experience an even greater risk of morbidity
and adverse psychosocial outcomes (Mitby et al, 2003; de Boer
et al, 2006; Oeffinger et al, 2006; Frobisher et al, 2007; Geenen et al,
2007; Pang et al, 2008; Lancashire et al, 2010; Hudson et al, 2013;
Armstrong et al, 2014). Conversely, survivors who received some
educational qualifications or worked in a managerial/professional
position were found to exhibit less mental health dysfunction
compared with their respective referents, which also generally
corresponds with previous reports (Zeltzer et al, 2008).
Limitations. Response bias due to selective responses should be
minimal due to our reasonably good response rate and the fact that
there was not a substantial difference in cancer and socio-
demographic characteristics between responders and non-respon-
ders of our questionnaire (Reulen et al, 2007). There is potentially
selection bias due to survival, particularly among the group of older
survivors as they may be healthier than their counterparts who did
not survive until questionnaire send-out. Another limitation in our
study is our comparison data, which may differ from our study
population in terms of socio-economic status. However, as the
results from our internal and external analyses broadly correspond
with one another, confounding by this factor should be limited.
Another limitation of this study is the lack of detailed treatment
information, which precluded any analyses being completed by
clinically relevant radiotherapy, chemotherapy, or surgery cate-
gories. However, in our analyses we have included FPN diagnosis,
which can serve as a proxy for treatment and still offer meaningful
clinical importance. In addition, this study has only assessed self-
reported mental health dysfunction. Although we do not identify
the risk of extreme mental health impairment (i.e., through
psychiatric admissions in hospitalisation registries), the purpose of
this study was to quantify daily mental health morbidities for all
individuals included in the study and assess in more detail the
degree of limitation in specific questions of mental health. Finally,
although the findings from this paper may not be generalisable for
children diagnosed with cancer after 1991, they are still highly
relevant to children treated more recently for whom treatment
intensity and long-term morbidity may be greater. We acknowl-
edge reassessment is necessary and recommend further analyses to
be conducted on the recently extended BCCSS cohort, which
includes 5-year survivors diagnosed from 1992–2006, and other
long-term follow-up studies.
Clinical recommendations. Although the need for long-term
psychological assessment and care is recognised (Chang, 1991;
Eiser et al, 2000; Wallace et al, 2001; Zeltzer et al, 2009), there
remain uncertainties as to how these individuals should be
assessed. A previous study reported that approximately only 35%
of childhood cancer survivors in the UK were on hospital follow-
up (Taylor et al, 2004). Consequently, as general practitioners
provide health care for the majority of these survivors (Oeffinger,
2004), routine psychological assessment, preferably using a
standardised and validated measure, should be integrated into
both long-term hospital follow-up clinics and general practitioner
Table 5. Percentage of individuals and corresponding 95% CIs reporting mental health dysfunction by attained age among the
general health population sample (OHLS) and childhood cancer survivors within the British Childhood Cancer Survivor Study,
adjusting for sex and age, for each questiona
Age at SF-36 Completion
16–24 25–34 35–44 45þ
Question statement Scale
General
population
sample All survivors
General
population
sample All survivors
General
population
sample All survivors
General
population
sample All survivors
Cut down on the amount of time
you spent on work or other
activities? (question 5a)
RE 14.4 (12.5–16.3) 12.9 (11.6–14.2) 12.1 (10.7–13.4) 15.4 (14.2–16.7) 12.1 (10.7–13.5) 17.2 (15.4–18.9) 12.8 (11.6–13.9) 17.5 (14.6–20.3)
Accomplished less than you would
like? (question 5b)
RE 22.6 (20.4–24.9) 19.0 (17.5–20.6) 20.6 (18.9–22.3) 20.8 (19.5–22.2) 21.6 (19.9–23.3) 23.6 (21.7–25.6) 21.8 (20.4–23.2) 24.9 (21.7–28.1)
Did work or other activities less
carefully than usual? (question 5c)
RE 21.6 (19.4–23.8) 14.8 (13.5–16.2) 17.5 (16.0–19.1) 16.7 (15.4–17.9) 18.1 (16.5–19.7) 18.1 (16.3–19.9) 15.6 (14.3–16.8) 18.1 (15.1–21.0)
Has your physical health or
emotional problems interfered
with your normal social activities?
(question 6)
SF 16.9 (14.9–18.9) 16.1 (14.7–17.5) 13.5 (12.1–15.0) 18.9 (17.6–20.2) 14.1 (12.6–15.5) 20.4 (18.5–22.2) 15.1 (13.9–16.3) 21.8 (18.7–24.9)
Has your health limited your social
activities? (question 9j)
SF 11.2 (9.6–12.9) 15.7 (14.2–17.1) 11.2 (9.9–12.5) 20.5 (19.1–21.8) 13.4 (12.0–14.8) 22.9 (20.9–24.8) 15.3 (14.1–16.5) 28.1 (24.7–31.5)
Have you been a very nervous
person? (question 9b)
MH 23.7 (21.4–25.9) 30.7 (28.9–32.5) 20.3 (18.6–21.9) 29.7 (28.1–31.2) 20.9 (19.2–22.6) 26.8 (24.8–28.8) 19.5 (18.2–20.8) 27.5 (24.2–30.8)
Have you felt so down in the
dumps that nothing could cheer
you up? (question 9c)
MH 21.2 (19.1–23.4) 25.3 (23.6–26.9) 17.6 (16.0–19.2) 25.7 (24.2–27.1) 18.1 (16.5–19.6) 24.5 (22.6–26.5) 17.6 (16.3–18.9) 18.7 (15.9–21.6)
Have you felt calm and peaceful?
(question 9d)
MH 44.8 (42.2–47.5) 43.2 (41.3–45.1) 45.0 (42.9–47.0) 46.8 (45.1–48.4) 47.1 (45.1–49.2) 47.7 (45.4–49.9) 39.1 (37.5–40.8) 43.1 (39.4–46.7)
Have you felt downhearted and
blue? (question 9f)
MH 31.1 (28.7–33.6) 35.1 (33.3–37.0) 29.4 (27.5–31.3) 36.4 (34.8–38.0) 28.4 (26.6–30.3) 35.7 (33.5–37.9) 26.4 (24.9–27.9) 34.1 (30.6–37.6)
Have you been a happy person?
(question 9h)
MH 22.0 (19.8–24.2) 21.5 (19.9–23.1) 24.1 (22.3–25.9) 24.5 (23.1–26.0) 27.1 (25.2–28.9) 27.1 (25.0–29.1) 26.2 (24.7–27.7) 27.8 (24.5–31.1)
Abbreviations: CIs¼ confidence intervals; MH¼mental health; RE¼ role emotional; SF¼ social functioning.
aTo view full questions, please refer to Figure 1.
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visits, especially for the vulnerable subgroup of survivors identified
in this study. To date, psychological provisions are lacking in late
effects services and are rare in the primary care setting. To improve
mental health, it is essential that recommendations for risk-based
care are readily available for general practitioners and ongoing
communication is coordinated across all sites and services
involved. Furthermore, surveillance for mental health dysfunction
and recommended interventions should be included in the
development of clinical guidelines, treatment summaries, and
patient care plans. As the results from this study suggest mental
health dysfunction is a concern across the lifespan for survivors, it
is imperative that equitable psychological support is continuously
available within general practices or specialist late effects services,
irrespective of the amount of time that has passed since initial
diagnosis, and that funding is allocated to allow for interventions.
Finally, the findings presented in this study also stress the
importance of educational attainment and employment on long-
term mental health. Educational support and career advisors
should be provided during and after treatment to ensure that
childhood cancer survivors achieve their full educational and
employment potential and have the same likelihood of academic
and professional success as their peers. By continually improving
the standard of care for mental health in childhood cancer
survivors, we work towards meeting the goal of psychosocial
oncology research, which is to facilitate patients’ adjustment to the
short- and long-term consequences of their treatment, recovery,
and survivorship so that quality of life is not reduced (Holland
et al, 1998).
CONCLUSION
Based upon the findings of this large population-based study,
childhood cancer survivors report significantly higher levels of
mental health dysfunction than those in the general population,
where excesses were observed particularly among CNS and bone
sarcoma survivors. Limitations were also observed to increase with
age, and thus it is important to emphasise the need for mental
health evaluation and services across the entire lifespan. There is
evidence that low educational attainment and being unemployed
or having never worked adversely impacts long-term mental
health. These findings provide an evidence base for risk
stratification and planning interventions.
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